Correlation Between Mereo BioPharma and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Mereo BioPharma and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Syndax Pharmaceuticals.
Diversification Opportunities for Mereo BioPharma and Syndax Pharmaceuticals
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Mereo and Syndax is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Syndax Pharmaceuticals
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Syndax Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Mereo BioPharma Group is 1.15 times less risky than Syndax Pharmaceuticals. The stock trades about -0.3 of its potential returns per unit of risk. The Syndax Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 1,424 in Syndax Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 104.00 from holding Syndax Pharmaceuticals or generate 7.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Mereo BioPharma Group vs. Syndax Pharmaceuticals
Performance |
Timeline |
Mereo BioPharma Group |
Syndax Pharmaceuticals |
Mereo BioPharma and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mereo BioPharma and Syndax Pharmaceuticals
The main advantage of trading using opposite Mereo BioPharma and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.Mereo BioPharma vs. Terns Pharmaceuticals | ||
Mereo BioPharma vs. PDS Biotechnology Corp | ||
Mereo BioPharma vs. Inozyme Pharma | ||
Mereo BioPharma vs. Hookipa Pharma |
Syndax Pharmaceuticals vs. Cogent Biosciences | ||
Syndax Pharmaceuticals vs. Cullinan Oncology LLC | ||
Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | ||
Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |